FORSYTH DOUGLAS
SEC CIK 1240801 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| INBX | Inhibrx Biosciences, Inc. | Dir | 227.1K | $1.32M | — | 3 | 2024-05-29 | 2026-09-08 |
Most active insiders at INBX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Viking Global Opportunities Parent GP LLC | 10% | — | $11.29M |
| 2 | Lappe Mark | CEO, Dir | $2.65M | — |
| 3 | Kayyem Jon Faiz | Dir | $1.57M | — |
| 4 | FORSYTH DOUGLAS | Dir | $286.6K | — |
| 5 | MANHARD KIMBERLY | Dir | — | $279.0K |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-09-08 16:26 | 2026-09-08 | INBX | Inhibrx Biosciences, Inc. | FORSYTH DOUGLAS | Dir | P - Purchase | $114.65 | +2,500 | 227.1K | +1% | +$286.6K |
| MI | 2024-08-26 | 2024-08-22+ | INBX | Inhibrx Biosciences, Inc. | FORSYTH DOUGLAS | Dir | P - Purchase | $13.83 | +75.0K | 224.6K | +50% | +$1.04M |
| DI | 2024-05-30 | 2024-05-29 | INBX | Inhibrx Biosciences, Inc. | FORSYTH DOUGLAS | Dir | A - Grant | — | +149.6K | 149.6K | New | — |
Purchase Sale Sale after option exercise All abbreviations